Captrust Financial Advisors Zynerba Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $288 - $430	-100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $331 - $654	100 New	100 $0
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $561 - $857	-100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.49 - $13.46 $849 - $1,346	100 New	100 $1,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.